Table 5.
Demographic Data, Comorbidities And Investigations Performed, According To Spirometry Results
| Results | Overall | FEV1/FVC ≥0.7 | FEV1/FVC <0.7 | Statistics | |
|---|---|---|---|---|---|
| Total | 175 | 37 (21.1%) | 138 (78.9%) | p<0.05 | |
| Gender | Female | 103 (58.9%) | 28 (75.7%) | 75 (54.3%) | p<0.05 |
| Male | 72 (41.1%) | 9 (24.3%) | 63 (45.7%) | ||
| Age (years) (n=174) | 56.5±11.5 | 56.1±10.8 | 56.8±11.7 | p=0.81 | |
| BMI (kg/m2) (n=171) | 25.9±7.1 | 28.5±8.7 | 23.4±6.3 | p<0.05 | |
| Smoking status (n=173) | Current | 59% | 67.60% | 56.60% | p=0.37 |
| Past | 34.10% | 24.30% | 36.80% | ||
| Never | 6.90% | 8.10% | 6.60% | ||
| Packs per year (n=80) | 27.7±24.0 | 30.6±26.1 | 24.7±17.2 | p=0.55 | |
| Comorbidity (n=172) | HTN | 14.50% | 11.10% | 15.40% | p=0.51 |
| DM | 11.60% | 8.30% | 12.50% | p=0.49 | |
| CRF | 9.90% | 11.10% | 9.60% | p=0.78 | |
| CAD | 7.60% | 5.60% | 8.10% | p=0.61 | |
| Stroke | 1.20% | 2.80% | 0.70% | p=0.31 | |
| Other | 49.40% | 52.80% | 48.50% | p=0.65 | |
| Other respiratory conditions (n=175) | Bronchiectasis | 49.90% | 35.10% | 55.10% | p<0.05 |
| Asthma | 36.60% | 45.90% | 34.10% | p=0.18 | |
| OSA | 10.30% | 5.40% | 11.60% | p=0.27 | |
| PHT | 4% | 2.70% | 4.30% | p=0.65 | |
| Lung cancer | 2.30% | 2.70% | 2.20% | p=0.85 | |
| ChT2RF | 1.10% | 0% | 1.40% | p=0.46 | |
| Echocardiogram (n=46) | Valvular anomalies | 26.10% | 6.50% | 19.60% | p=0.58 |
| PHT | 10.90% | 2.20% | 8.70% | p=0.98 | |
| RHF | 10.90% | 2.20% | 8.70% | p=0.98 | |
| LV failure | 8.70% | 0% | 8.70% | p=0.30 | |
| Normal | 43.50% | 8.70% | 34.80% | p=0.95 | |
Note: Bold text indicates significance.
Abbreviations: BMI, body mass index; HTN, hypertension; DM, diabetes mellitus; CRF, chronic renal failure; CAD, coronary artery disease; OSA, obstructive sleep apnoea; PHT, pulmonary hypertension; ChT2RF, chronic type 2 respiratory failure; RHF, right heart failure; LV failure, left ventricular failure.